SYK · 10-Q · 2026Q3 · Full report

Operating Income and Margins

STRYKER CORP · 2026-10-30 · Importance 54 · Surprise 40

Third-quarter operating income was $1,034 million, down from $1,135 million, and operating margin fell to 15.9% from 18.7%.,Nine-month operating income increased to $3,629 million from $3,085 million, with operating margin rising to 19.0% from 17.2%.,Third-quarter MedSurg and Neurotechnology operating margin rose to 28.7% from 26.1%, primarily due to lower SG&A, lower manufacturing and supply-chain costs, and higher unit volumes.,Third-quarter Orthopaedics operating margin declined to 31.2% from 32.4%, as higher SG&A and manufacturing and supply-chain costs partly offset higher unit volumes.

Key facts

• In the three months of 2026, adjusted operating income margin was 26.2%, adjusted net earnings were $1,357 million, and adjusted diluted EPS was $3.52, up 10.3%. source
• In the nine months of 2026, adjusted operating income margin was 25.0%, adjusted net earnings were $3,785 million, and adjusted diluted EPS was $9.81, up 7.1%. source
• In the three months of 2026, operating income margin was 15.9%, net earnings were $753 million, and diluted EPS was $1.96. source
• In the nine months of 2026, operating income margin was 19.0%, net earnings were $2,774 million, and diluted EPS was $7.19. source
• Operating income was $1,034 million in the three months, and operating margin decreased to 15.9% from 18.7%. source
• Operating income was $3,629 million in the nine months, and operating margin increased to 19.0% from 17.2%. source
• In the three months, MedSurg and Neurotechnology operating margin rose to 28.7% from 26.1%, while Orthopaedics operating margin fell to 31.2% from 32.4%. source
• In the nine months, MedSurg and Neurotechnology operating margin rose to 26.4% from 25.5%, while Orthopaedics operating margin declined to 31.8% from 32.0%. source